Literature DB >> 33664363

The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017.

Mimi Zhai1, Zhide Liu2,3, Jianhai Long4, Qingxiang Zhou2, Leping Yang2, Qin Zhou2, Sushun Liu5, Yu Dai6.   

Abstract

Nonalcoholic steatohepatitis (NASH) has rapidly become the most common cause of chronic liver diseases. We aimed to explore the incidence and distribution characteristics of NASH by sex, region and sociodemographic index (SDI). We collected data, including sex and region, on NASH-related liver cirrhosis from the 2017 GBD study. The age-standardized incidence rates (ASRs) and estimated annual percentage changes (EAPCs) were used to estimate the incidence trend and distribution characteristics. Globally, the incidence of liver cirrhosis caused by NASH increased from 178,430 cases in 1990 to 367,780 cases in 2017, an increase of approximately 105.56%. The ASR of NASH increased by an average of 1.35% per year (95% CI 1.28-1.42). Meanwhile, large differences in the ASR and the EAPC were observed across regions. The middle-high SDI region had the highest increase among all five SDI regions, followed by middle SDI region. In addition, Eastern Europe, Andean Latin America and Central Asia showed a more significant growth trend of ASR. In contrast, the high SDI region demonstrated the slowest increasing trend of ASR, and the high-income Asia Pacific demonstrated a decreasing trend among the 21 regions. Liver cirrhosis has caused a huge and rising health burden in many countries and regions. In addition, with the growth of obesity, population and aging, NASH might replace viral hepatitis as the most important cause of liver cirrhosis in the near future. Therefore, appropriate interventions are needed in coming decades to realize early diagnosis and prevention of NASH-related liver cirrhosis.

Entities:  

Mesh:

Year:  2021        PMID: 33664363      PMCID: PMC7933440          DOI: 10.1038/s41598-021-84577-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  51 in total

Review 1.  Epidemiology and natural history of non-alcoholic fatty liver disease.

Authors:  Yousef Fazel; Aaron B Koenig; Mehmet Sayiner; Zachary D Goodman; Zobair M Younossi
Journal:  Metabolism       Date:  2016-01-29       Impact factor: 8.694

Review 2.  Obesity and public health in the Kingdom of Saudi Arabia.

Authors:  Erica DeNicola; Omar S Aburizaiza; Azhar Siddique; Haider Khwaja; David O Carpenter
Journal:  Rev Environ Health       Date:  2015       Impact factor: 3.458

3.  Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis.

Authors:  Feng Zhou; Jianghua Zhou; Wenxin Wang; Xiao-Jing Zhang; Yan-Xiao Ji; Peng Zhang; Zhi-Gang She; Lihua Zhu; Jingjing Cai; Hongliang Li
Journal:  Hepatology       Date:  2019-10       Impact factor: 17.425

4.  Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.

Authors:  Kausik Das; Kshaunish Das; Partha S Mukherjee; Alip Ghosh; Sumantra Ghosh; Asit R Mridha; Tapan Dhibar; Bhaskar Bhattacharya; Dilip Bhattacharya; Byomkesh Manna; Gopal K Dhali; Amal Santra; Abhijit Chowdhury
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

5.  Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study.

Authors:  Claudia Della Corte; Antonella Mosca; Andrea Vania; Arianna Alterio; Salvatore Iasevoli; Valerio Nobili
Journal:  Nutrition       Date:  2017-02-27       Impact factor: 4.008

6.  Worldwide mortality from cirrhosis: an update to 2002.

Authors:  Cristina Bosetti; Fabio Levi; Franca Lucchini; Witold A Zatonski; Eva Negri; Carlo La Vecchia
Journal:  J Hepatol       Date:  2007-02-16       Impact factor: 25.083

7.  Changing incidence patterns of hepatocellular carcinoma among age groups in Taiwan.

Authors:  Giun-Yi Hung; Jiun-Lin Horng; Hsiu-Ju Yen; Chih-Ying Lee; Li-Yih Lin
Journal:  J Hepatol       Date:  2015-08-06       Impact factor: 25.083

8.  Liver fat in the metabolic syndrome.

Authors:  Anna Kotronen; Jukka Westerbacka; Robert Bergholm; Kirsi H Pietiläinen; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2007-06-26       Impact factor: 5.958

9.  Obesity and the extent of liver damage among adult New Zealanders: findings from a national survey.

Authors:  K J Coppell; J C Miller; A R Gray; M Schultz; J I Mann; W R Parnell
Journal:  Obes Sci Pract       Date:  2015-11-24

10.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.

Authors:  Ali A Mokdad; Alan D Lopez; Saied Shahraz; Rafael Lozano; Ali H Mokdad; Jeff Stanaway; Christopher J L Murray; Mohsen Naghavi
Journal:  BMC Med       Date:  2014-09-18       Impact factor: 8.775

View more
  3 in total

1.  Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.

Authors:  Anshuman Elhence; Bhavik Bansal; Hardik Gupta; Abhinav Anand; Thakur P Singh; Amit Goel
Journal:  J Clin Exp Hepatol       Date:  2021-11-25

Review 2.  Functional heterogeneity of CD4+ T cells in liver inflammation.

Authors:  Franziska Muscate; Anna Woestemeier; Nicola Gagliani
Journal:  Semin Immunopathol       Date:  2021-08-31       Impact factor: 9.623

3.  Hepatopulmonary Syndrome: A Nationwide Analysis of Epidemiological Trends and Outcomes From 2012 to 2018.

Authors:  Dushyant Singh Dahiya; Asim Kichloo; Hafeez Shaka; Jagmeet Singh; Gurdeep Singh; Farah Wani; Sundas Masudi; Hazique Koul; Sailaja Pisipati
Journal:  Gastroenterology Res       Date:  2021-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.